CD8A and neoplasm: Treatment of subcutaneous MC38 tumors with these NPs inhibited tumor progression, which was associated with increased infiltration of CD8+ T cells and expression of CD8+ T cell-associated inflammatory factors (perforin, GzmA, and GzmB).